Edison, NJ, United States of America

Michael J Torntore

This inventor holds 1 USPTO granted patent. Top assignee: Gluconova, LLC. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Torntore. Retrieved from https://idiyas.com/inventor/michael-j-torntore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J Torntore: Innovator in Pharmaceutical Complexes

Introduction

Michael J Torntore is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug complexes. His innovative work focuses on enhancing the stability and efficacy of therapeutic drugs.

Latest Patents

Michael J Torntore holds a patent for "Halide-free glucosamine-acidic drug complexes." This patent describes a complex of glucosamine with a purity of at least about 99 wt. % and a maximum halide content of about 0.01 wt. %. The complex is designed to be stabilized by coating it with at least one pharmaceutically acceptable polymer. These polymers include carboxypolymethylene, polyethylene glycol, povidone, polyacrylic acid, and polysaccharides. The resultant coated complex is stable upon exposure to ambient temperature and the atmosphere, making it suitable for various therapeutic drugs.

Career Highlights

Michael J Torntore is associated with Gluconova, LLC, where he continues to innovate in the pharmaceutical sector. His work has the potential to impact various classes of therapeutic drugs, including analgesics, antibiotics, and antihypertensives.

Collaborations

Michael collaborates with Vilas M Chopdekar, contributing to advancements in their field.

Conclusion

Michael J Torntore's contributions to pharmaceutical innovations demonstrate his commitment to improving drug stability and efficacy. His work continues to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…